scholarly article | Q13442814 |
P819 | ADS bibcode | 1988PNAS...85.1544L |
P356 | DOI | 10.1073/PNAS.85.5.1544 |
P932 | PMC publication ID | 279809 |
P698 | PubMed publication ID | 3278318 |
P5875 | ResearchGate publication ID | 19878627 |
P2093 | author name string | E Engvall | |
I Leivo | |||
P2860 | cites work | Appearance and distribution of collagens and laminin in the early mouse embryo | Q72136085 |
Enzyme immunoassay ELISA and EMIT | Q72153601 | ||
Demonstration of laminin, a basement membrane glycoprotein, in routinely processed formalin-fixed human tissues | Q72681507 | ||
Myelin Basic Protein Deposition in the Optic and Sciatic Nerves of Dysmyelinating Mutants Quaking, Jimpy, Trembler, MLD, and Shiverer During Development | Q72712550 | ||
HISTOCHEMICAL DIFFERENTIATION OF SKELETAL MUSCLE IN FOETAL AND NEWBORN MICE | Q77179063 | ||
C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast | Q24680329 | ||
A fibroblast chondroitin sulfate proteoglycan core protein contains lectin-like and growth factor-like sequences | Q28280358 | ||
Laminin–a glycoprotein from basement membranes | Q34083862 | ||
Monoclonal antibodies to laminin reveal the heterogeneity of basement membranes in the developing and adult mouse tissues | Q34257345 | ||
Human laminin isolated in a nearly intact, biologically active form from placenta by limited proteolysis | Q34259544 | ||
Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure | Q35875555 | ||
A monoclonal antibody that blocks the activity of a neurite regeneration-promoting factor: studies on the binding site and its localization in vivo | Q36215616 | ||
Mapping of domains in human laminin using monoclonal antibodies: localization of the neurite-promoting site | Q36216567 | ||
Isolation of a heparan sulfate-containing proteoglycan from basement membrane. | Q36400682 | ||
Properties of a basement membrane-related glycoprotein synthesized in culture by a mouse embryonal carcinoma-derived cell line | Q39553287 | ||
Type VII collagen is a major structural component of anchoring fibrils | Q41511070 | ||
Identification of sarcolemma-associated antigens with differential distributions on fast and slow skeletal muscle fibers | Q41516013 | ||
Monoclonal antibody analysis of ocular basement membranes during development | Q41542532 | ||
IMMUNOHISTOCHEMICAL ANALYSIS OF BASEMENT MEMBRANES OF THE MOUSE | Q42037291 | ||
Cholinesterase is associated with the basal lamina at the neuromuscular junction | Q42441420 | ||
Entactin, a novel basal lamina-associated sulfated glycoprotein | Q42451356 | ||
Development of basal lamina in synaptic and extrasynaptic portions of embryonic rat muscle | Q42455556 | ||
Masking of antigenic sites of fibronectin by glycosaminoglycans in ethanol-fixed embryonic tissue | Q44074758 | ||
Heterogeneity of basement membranes of the human genitourinary tract revealed by sequential immunofluorescence staining with monoclonal antibodies to laminin | Q44293423 | ||
Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin | Q44293911 | ||
The collagenous component of lens basement membrane. The isolation and characterization of an alpha chain size collagenous peptide and its relationship to newly synthesized lens components | Q47315183 | ||
Type VI collagen. Studies on its localization, structure, and biosynthetic form with monoclonal antibodies | Q54477442 | ||
Binding of soluble form of fibroblast surface protein, fibronectin, to collagen | Q67675651 | ||
Basement membrane diversity detected by monoclonal antibodies | Q70339027 | ||
Preparation and characterization of the different types of collagen | Q70353099 | ||
Laminin from rat yolk sac tumor: isolation, partial characterization, and comparison with mouse laminin | Q71724758 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Schwann cell | Q465621 |
P304 | page(s) | 1544-1548 | |
P577 | publication date | 1988-03-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development | |
P478 | volume | 85 |
Q73179591 | 27 kDa extracellular matrix protein revealed by a monoclonal antibody raised against rat testis |
Q36437603 | A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion |
Q49963380 | A Homozygous LAMA2 Mutation of c.818G>A Caused Partial Merosin Deficiency in a Japanese patient. |
Q33553723 | A biologically active sequence of the laminin alpha2 large globular 1 domain promotes cell adhesion through syndecan-1 by inducing phosphorylation and membrane localization of protein kinase Cdelta |
Q34290873 | A journey to the world of glycobiology |
Q36291506 | A novel early onset phenotype in a zebrafish model of merosin deficient congenital muscular dystrophy |
Q36382518 | A recombinant tail-less integrin beta 4 subunit disrupts hemidesmosomes, but does not suppress alpha 6 beta 4-mediated cell adhesion to laminins. |
Q41585727 | A variant form of laminin is responsible for the neurite outgrowth-promoting activity in conditioned medium from a squamous carcinoma cell line |
Q28588415 | Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice |
Q52199371 | Active peptides from the carboxyl-terminal globular domain of laminin alpha2 and Drosophila alpha chains. |
Q41585722 | Adhesion promoting property of laminin from normal tissue and from a tumorigenic cell line |
Q35793464 | Altered expression of laminins in Crohn's disease small intestinal mucosa |
Q33922811 | Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin |
Q41149417 | Assessment of laminin-mediated glioma invasion in vitro and by glioma tumors engrafted within rat spinal cord |
Q41939463 | Assignment of laminin heavy chains using the lectin Ricinus communis agglutinin-1. |
Q62731349 | Bacterial and host-derived cationic proteins bind α2-laminins and enhance Mycobacterium leprae attachment to human Schwann cells |
Q42486651 | Basal lamina development in chicken muscle spindles |
Q34233012 | Basement Membrane Proteins: Structure, Assembly, and Cellular Interactions |
Q45295628 | Basement membrane proteins in salivary gland tumours. Distribution of type IV collagen and laminin |
Q91908779 | Beta-sarcoglycan-deficient muscular dystrophy presenting as chronic bronchopneumonia in a young cat |
Q92014464 | Cell Biology of Intracellular Adaptation of Mycobacterium leprae in the Peripheral Nervous System |
Q40816718 | Cell adhesion and migration properties of beta 2-integrin negative polymorphonuclear granulocytes on defined extracellular matrix molecules. Relevance for leukocyte extravasation. |
Q42061880 | Cell elongation induces laminin alpha2 chain expression in mouse embryonic mesenchymal cells: role in visceral myogenesis |
Q91387651 | Cellular rescue in a zebrafish model of congenital muscular dystrophy type 1A |
Q36058183 | Cellular responses to extracellular matrix |
Q74602530 | Characterization of the transmembrane molecular architecture of the dystroglycan complex in schwann cells |
Q28555030 | Chondroitinase C Selectively Degrades Chondroitin Sulfate Glycosaminoglycans that Inhibit Axonal Growth within the Endoneurium of Peripheral Nerve |
Q42448626 | Comparison of neurite outgrowth induced by intact and injured sciatic nerves: a confocal and functional analysis. |
Q42480845 | Composition in situ and in vitro of vascular smooth muscle laminin in the rat. |
Q48881167 | Congenital muscular dystrophy with laminin alpha 2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry |
Q37528083 | Congenital muscular dystrophy. Part II: a review of pathogenesis and therapeutic perspectives |
Q38291309 | Contributions of the LG modules and furin processing to laminin-2 functions |
Q33547058 | Creatine kinase, cell membrane and Duchenne muscular dystrophy |
Q91906240 | Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy |
Q35493060 | Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse |
Q71980382 | Deficiency of laminin α2‐Chain mRNA in muscle in a patient with merosin‐negative congenital muscular dystrophy |
Q34111710 | Defining the interaction of the Treponema pallidum adhesin Tp0751 with laminin |
Q36532803 | Differential distribution and modulation of expression of alpha 1/beta 1 integrin on human endothelial cells |
Q42523795 | Differential expression of fibronectin splice variants, oncofetal glycosylated fibronectin and laminin isoforms in nodular palmar fibromatosis |
Q28139244 | Differential expression of laminin alpha chains during proliferative and differentiation stages in a model for skin morphogenesis |
Q41954471 | Differential expression of laminin chains and their integrin receptors in human gastric mucosa |
Q42487339 | Differential expression of laminin isoforms and alpha 6-beta 4 integrin subunits in the developing human and mouse intestine. |
Q41340435 | Differential expression of laminin isoforms in diabetic nephropathy and other renal diseases |
Q48656854 | Differential laminin isoform expression in the developing rat olfactory system. |
Q24791491 | Diseased muscles that lack dystrophin or laminin-alpha2 have altered compositions and proliferation of mononuclear cell populations |
Q34440606 | Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms |
Q41852701 | Distinct changes in the laminin composition of basement membranes in human seminiferous tubules during development and degeneration. |
Q28593330 | Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice |
Q24304482 | Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits |
Q36619941 | Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma |
Q35596525 | Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo |
Q28238540 | Dystroglycan is a binding protein of laminin and merosin in peripheral nerve |
Q46673302 | Effects of conformational activation of integrin alpha 1I and alpha 2I domains on selective recognition of laminin and collagen subtypes |
Q48466850 | Electrophysiology of the neuromuscular junction of the laminin-2 (merosin) deficient C57 BL/6J dy2J/dy2J dystrophic mouse |
Q45879455 | Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies |
Q36326348 | Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis |
Q30439162 | Expression and in vitro function of beta 1-integrin laminin receptors in the developing avian ciliary ganglion. |
Q41667673 | Expression and potential role of the extracellular matrix in hepatic ontogenesis: a review |
Q41519071 | Expression of beta 1 integrins in sensory neurons of the dorsal root ganglion and their functions in neurite outgrowth on two laminin isoforms |
Q52207469 | Expression of laminin subunits in human fetal skeletal muscle |
Q35548316 | Expression of laminins and their integrin receptors in different conditions of synovial membrane and synovial membrane-like interface tissue |
Q37957984 | Extracellular matrix and neuronal movement |
Q40412676 | Extracellular matrix components in intestinal development |
Q37178903 | Extracellular matrix molecules and their receptors: functions in neural development |
Q35763916 | Extrasynaptic location of laminin beta 2 chain in developing and adult human skeletal muscle |
Q37314376 | Fluctuating hearing loss associated with Halo vest application |
Q40714810 | Function of laminins and laminin-binding integrins in gingival epithelial cell adhesion |
Q42646609 | Further biochemical characterization of Mycobacterium leprae laminin-binding proteins |
Q47927446 | Genetic Models in Applied Physiology. Merosin deficiency leads to alterations in passive and active skeletal muscle mechanics |
Q33818891 | How does Mycobacterium leprae target the peripheral nervous system? |
Q24673551 | Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues |
Q41572091 | Human neoplastic submandibular intercalated duct cells express an acinar phenotype when cultured on a basement membrane matrix |
Q64248716 | Identification of Candidate Protein Markers in Skeletal Muscle of Laminin-211-Deficient CMD Type 1A-Patients |
Q58109219 | Identification of homozygous and heterozygous dy 2J mice by PCR |
Q68074378 | Immunofluorescent localization of collagen types I, III, IV, V, fibronectin, laminin, entactin, and heparan sulphate proteoglycan in human immature placenta |
Q39378966 | Immunohistochemical localization of laminin and type IV collagen in human cutaneous sensory nerve formations |
Q33787898 | Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy |
Q35830467 | Increased steady-state levels of mRNA coding for extracellular matrix components in kidneys of NZB/W F1 mice |
Q42493929 | Influence of laminin-2 on Schwann cell-axon interactions |
Q35747893 | Integrin alpha 7 beta 1 in muscular dystrophy/myopathy of unknown etiology. |
Q45288511 | Integrin repertoire on myogenic cells changes during the course of primary myogenesis in the mouse |
Q40769921 | Integrin-type extracellular matrix receptors in cancer and inflammation |
Q28249995 | Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy |
Q73738821 | Interaction of merosin (laminin 2) with very late activation antigen-6 is necessary for the survival of CD4+ CD8+ immature thymocytes |
Q35764693 | Intestinal epithelial restitution. Involvement of specific laminin isoforms and integrin laminin receptors in wound closure of a transformed model epithelium |
Q74458818 | Laminin alpha 2 (merosin)-deficient muscular dystrophy and demyelinating neuropathy in two cats |
Q42511130 | Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas |
Q52527453 | Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. |
Q38622731 | Laminin alpha2 chain-positive vessels and epidermal growth factor in lung neuroendocrine carcinoma: a model of a novel cooperative role of laminin-2 and epidermal growth factor in vessel neoplastic invasion and metastasis |
Q74138464 | Laminin and alpha-dystroglycan mediate acetylcholine receptor aggregation via a MuSK-independent pathway |
Q44223039 | Laminin chains in rat and human peripheral nerve: distribution and regulation during development and after axonal injury |
Q42526734 | Laminin chains in the basement membranes of human thymus |
Q26858989 | Laminin isoforms in endothelial and perivascular basement membranes |
Q42452875 | Laminin isoforms in human embryonic stem cells: synthesis, receptor usage and growth support |
Q42212650 | Laminin production and basement membrane deposition by mesenchymal stem cells upon adipogenic differentiation. |
Q40876104 | Laminin variants: why, where and when? |
Q58108925 | Laminin α2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice |
Q34464317 | Laminin-5 in the progression of carcinomas |
Q28565855 | Laminin-alpha2 chain-like antigens in CNS dendritic spines |
Q36273941 | Laminin-induced acetylcholine receptor clustering: an alternative pathway |
Q24302103 | Laminins 2 (alpha2beta1gamma1, Lm-211) and 8 (alpha4beta1gamma1, Lm-411) are synthesized and secreted by tooth pulp fibroblasts and differentially promote neurite outgrowth from trigeminal ganglion sensory neurons |
Q34071975 | Laminins and human disease |
Q48643716 | Laminins of the adult mammalian CNS; laminin-alpha2 (merosin M-) chain immunoreactivity is associated with neuronal processes |
Q71666651 | Laminins, tenascin and type VII collagen in colorectal mucosa |
Q34071960 | Laminins: structure and genetic regulation |
Q80616129 | Long-term follow-up of laminin alpha2 (merosin)-deficient muscular dystrophy in a cat |
Q40087368 | Lutheran blood group antigen as a receptor for alpha5 laminins in gingival epithelia |
Q24319122 | MLC1 is associated with the dystrophin-glycoprotein complex at astrocytic endfeet |
Q36237447 | Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival |
Q46310121 | Merosin and laminin. Molecular relationship and role in nerve-muscle development |
Q24323587 | Merosin, a tissue-specific basement membrane protein, is a laminin-like protein |
Q37384623 | Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models |
Q74307848 | Merosin-deficient congenital muscular dystrophy: neuropathology case reports |
Q36629201 | Merosin-negative congenital muscular dystrophy: Report of five cases |
Q28238601 | Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain |
Q34137688 | Molecular basis for the peripheral nerve predilection of Mycobacterium leprae |
Q24298375 | Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere |
Q41291111 | Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects |
Q34319775 | Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene |
Q54076628 | Muscle membrane-skeleton protein changes and histopathological characterization of muscle-eye-brain disease. |
Q37105883 | Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats. |
Q58109174 | Muscular transverse relaxation time measurement by magnetic resonance imaging at 4 Tesla in normal and dystrophic dy/dy and dy2j/dy2j mice |
Q24308817 | Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy |
Q40925883 | Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles |
Q42268136 | Nerve growth factor signalling in pathology and regeneration of human teeth |
Q59647724 | Neural Targeting of Mycobacterium leprae Mediated by the G Domain of the Laminin-α2 Chain |
Q77557277 | Nonmuscular involvement in merosin-negative congenital muscular dystrophy |
Q62731253 | PGL I expression in live bacteria allows activation of a CD206/PPARγ cross-talk that may contribute to successful Mycobacterium leprae colonization of peripheral nerves |
Q46576508 | Partial cloning of the M subunit of laminin from adult rat lipocytes: expression of the M subunit by cells isolated from normal and injured liver |
Q36236670 | Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation |
Q24529573 | Primary structure of the human laminin A chain. Limited expression in human tissues |
Q67672689 | Production of two variant laminin forms by endothelial cells and shift of their relative levels by angiostatic steroids |
Q42829740 | Protein kinase Cα/β inhibitor Gö6976 promotes PC12 cell adhesion and spreading through membrane recruitment and activation of protein kinase Cδ. |
Q40599747 | Rac regulates integrin-mediated endothelial cell adhesion and migration on laminin-8. |
Q38578946 | Role of the extracellular matrix in neural crest cell migration. |
Q22001192 | Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies |
Q28296180 | Structure of the human laminin alpha2-chain gene (LAMA2), which is affected in congenital muscular dystrophy |
Q35882763 | Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein. |
Q36532915 | Synthetic peptides from the carboxy-terminal globular domain of the A chain of laminin: their ability to promote cell adhesion and neurite outgrowth, and interact with heparin and the beta 1 integrin subunit |
Q34795383 | Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination |
Q43108534 | The dermal-epidermal junction of human skin contains a novel laminin variant |
Q42516252 | The junctional epithelium around murine teeth differs from gingival epithelium in its basement membrane composition |
Q24678511 | The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform |
Q34646757 | The laminin family |
Q40883080 | The laminins: a family of basement membrane glycoproteins important in cell differentiation and tumor metastases |
Q38950913 | The role of laminins in the organization and function of neuromuscular junctions |
Q36222987 | The spatial organization of Descemet's membrane-associated type IV collagen in the avian cornea |
Q36746576 | Up-regulation of the integrin alpha 1/beta 1 in human neuroblastoma cells differentiated by retinoic acid: correlation with increased neurite outgrowth response to laminin |
Q34100017 | Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2. |
Search more.